NPPB and hydrops fetalis: In the subanalysis of STRONG-HF (The Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP Testing, of Heart Failure Therapies) trial, which enrolled patients hospitalized for acute HF with any LVEF and not treated with full doses of renin-angiotensin system (RAS) blockers and beta-blockers, rapid uptitration of oral medications for HF and close follow-up reduced 180-day death and HF rehospitalization irrespective of LVEF.10